YCM
EGRX

Yousif Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Yousif Capital Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8,522
Closed -$225K – 1980
2022
Q3 		$225K Sell
8,522
-476
-5% -$17.5K ﹤0.01% 1782
2022
Q2 		$400K Sell
8,998
-1,275
-12% -$58.6K 0.01% 1632
2022
Q1 		$508K Buy
10,273
+1,080
+12% +$51.8K 0.01% 1632
2021
Q4 		$468K Buy
+9,193
New +$476K ﹤0.01% 1684

Other funds holding EGRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SGCIA
Smith Graham & Co Investment Advisors Houston, Texas $868M AUM 24.69% 1-Year Est. Return

Yousif Capital Management's EGRX Position: Q4 2022 in Review

Yousif Capital Management sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q4 2022, closing a stake of 8,522 shares — an estimated $225K sold.

Yousif Capital Management first reported a position in EGRX in Q4 2021 and held it in 4 quarters. The position peaked at $508K in Q1 2022. 152 funds tracked by Wall St. Rank hold EGRX as of Q4 2022.

  • Yousif Capital Management reported no remaining Eagle Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • Yousif Capital Management sold 8,522 Eagle Pharmaceuticals, Inc. shares in Q4 2022, an estimated $225K.
  • Yousif Capital Management first reported a position in Eagle Pharmaceuticals, Inc. in Q4 2021 and held it in 4 quarters.
  • Yousif Capital Management's Eagle Pharmaceuticals, Inc. position peaked at $508K in Q1 2022.
  • 152 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2022.

Based on Yousif Capital Management's 13F filing for Q4 2022, filed 9 Jan 2023.